lazertinibum 240 mg ut lazertinibi mesilas monohydricus 289.44 mg, silica hydrophobica colloidalis, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 2.4 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Lazertinibum
240 mg
Inactive agents
additional_information
(Nigrum)
(Rubrum)
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum
Überzug
E 171
color.
E 172
color.
Glyceroli Monocaprylocapras
Magnesii Stearas
Mannitol
Poly(Alcohol Vinylicus)
Pro Compresso Obducto
Silica Hydrophobica Colloidalis
Talcum
Source
Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
